Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 14;57(6):621.
doi: 10.3390/medicina57060621.

TGF-β Physiology as a Novel Therapeutic Target Regarding Autoimmune Thyroid Diseases: Where Do We Stand and What to Expect

Efstratios Kardalas  1 , Spyridoula Maraka  2 , Maria Papagianni  3 , George Paltoglou  1 , Charalampos Siristatidis  4 , George Mastorakos  1
Affiliations
Review

TGF-β Physiology as a Novel Therapeutic Target Regarding Autoimmune Thyroid Diseases: Where Do We Stand and What to Expect

Efstratios Kardalas et al. Medicina (Kaunas). .

Abstract

Transforming growth factor beta (TGF-β), as a master regulator of immune response, is deeply implicated in the complex pathophysiology and development of autoimmune thyroid diseases. Based on the close interplay between thyroid autoimmunity and TGF-β, scientific interest was shifted to the understanding of the possible role of this molecule regarding the diagnosis, prognosis, and therapy of these diseases. The main aim of this review is to present research data about possible treatment options based on the role of TGF-β in thyroid autoimmunity. Suggested TGF-β-mediated therapeutic strategies regarding autoimmune thyroid diseases include either the enhancement of its immunosuppressive role or inhibition of its facilitatory role in thyroid autoimmunity. For example, the application of hr-TGF-β can be used to bolster the inhibitory role of TGF-β regarding the development of thyroid diseases, whereas anti-TGF-β antibodies and similar molecules could impede its immune-promoting effects by blocking different levels of TGF-β biosynthesis and activation pathways. In conclusion, TGF-β could evolve to a promising, novel therapeutic tool for thyroid autoimmunity.

Keywords: TGF-β; autoimmune thyroid diseases; immune cells; pregnancy; therapy; thyroid gland; thyroiditis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Implication of TGF-β in the development of the autoimmune thyroid diseases.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Yang L., Pang Y., Moses H.L. TGF-β and immune cells: An important regulatory axis in the tumor microenvironment and progression. Trends Immunol. 2010;31:220–227. doi: 10.1016/j.it.2010.04.002. - DOI - PMC - PubMed
    1. Widder J., Dorfinger K., Wilfing A., Trieb K., Pirich K., Loebenstein R., Niederle B., Gessl A., Spitzauer S., Grubeck-Loebenstein B. The immunoregulatory influence of transforming growth factor beta in thyroid autoimmunity: TGF β inhibits autoreactivity in Graves’ disease. J. Autoimmun. 1991;4:689–701. doi: 10.1016/0896-8411(91)90186-G. - DOI - PubMed
    1. Ouyang W., Filvaroff E., Hu Y., Grogan J. Novel therapeutic targets along the Th17 pathway. Eur. J. Immunol. 2009;39:670–675. doi: 10.1002/eji.200839105. - DOI - PubMed
    1. Syed V. TGF-β Signaling in Cancer. J. Cell. Biochem. 2016;117:1279–1287. doi: 10.1002/jcb.25496. - DOI - PubMed
    1. Morikawa M., Derynck R., Miyazono K. TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology. Cold Spring Harb. Perspect. Biol. 2016;8:a021873. doi: 10.1101/cshperspect.a021873. - DOI - PMC - PubMed

Substances